[ad_1]
The Israeli drug manufacturer will remember all batches of combined amlodipine-valsartan and amlodipine-valsartan-hydrochlorothiazide tablets due to an impurity in an ingredient manufactured by a Mylan unit based in India, announced the FDA (Food and Drug Administration) Tuesday. REUTERS | November 28, 2018, 7:47 am ETT
Source link
